2025 Q4 -tulosraportti
82 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Viimeisin osinko
4,50%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 | - | - | ||
| 20 | - | - | ||
| 702 | - | - | ||
| 571 | - | - | ||
| 129 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·20 min sittenStock market gains on the way in Europe, here is Monday's financial overview. We are entering a hectic week, where we will get fresh insights into some of the largest and most influential companies both domestically and abroad. European stocks are set to become more valuable when stock trading kicks off in Europe. Futures for European stocks currently indicate price increases of 0.3 pct. when looking at the Euro Stoxx 50 index. The index covers 50 large European companies. Good day to all ☀️
8 t sitten8 t sittenFra Reddit - Imagine this conversation: "Sry honey, I'm gonna lose less weight, feel nauseous and you will have to wrap your willy for 30 days for likely quite a few times...." "Or.... i could just take the other pill, priced the exact same, that makes me thinner, feel healthier, and oh yeah,... i have to just wait a few minutes in the morning before eating, which hey.... i wasn't planning to do anyway because I'm planning to lose weight right!" Easiest choice ever. LLY is so f'd
·9 t sitten · MuokattuCan recommend this on Reddit (might explain why Foundayo has been slow to start so far): https://www.reddit.com/r/Burryology/comments/1sv6rkz/lly_the_foundayo_bull_case_requires_assuming/ "- Here's the kicker I suspect nobody is pricing in. Foundayo's FDA label requires women on oral birth control to either switch to non-oral contraception OR use condoms for 30 days after starting AND 30 days after each dose escalation. That's 3-6 months of continuous backup contraception to reach max dose.[2] - Oral Wegovy has no such warning. Semaglutide was directly studied for oral contraceptive interaction. No clinically meaningful effect. Zero friction, so to say." And: "One final thing is Wegovy pill already has more weight loss but lot.of users are kind of bio hacking it now - they realized if you extend the fasting window to 1-2 hours it can dramatically increase the effectiveness. The 30 minute was made for convenience but concentration is almost doubled in your blood if you wait 1-2 hours. That's not a trick you can do with Foundayo since it has no fasting restrictions so the advantage in that aspect is now a disadvantage."
·9 t sittenProtector you might want to read along here before you babble too much !!!
·12 t sitten
·9 t sittenThere is no doubt that Q1 and Q2 will be challenged. It has already been announced that 2026 will bring a double-digit underlying decline. Wegovy pill form has enormous success, but it cannot change the picture yet. If we are lucky, we will see results in Q2 that make it less severe, but we can hope it is correct that EMA will announce something very soon. If Wegovy pill form comes to the European market in 2-3 months, then Wegovy pill form might grow so large that it cancels out the expected underlying double-digit decline. Honestly, when it comes to market in Europe, I am convinced that for many, many months, the number of patients/users will grow month after month. Clearly, the sooner it is approved, the better, but if it comes to market in July, I believe that globally by end of December it can yield 4-6 million patients/users.- ·16 t sittenI think the American and also analysts will soon wake up. They have until now set price targets based on Novo's share price and not Novo's real value. Now some current sales figures came out last Friday. It shows that doctors prefer to prescribe the Novo pill. That is so clear with the uncertainty surrounding Eli Lilly's pill with side effects. Novo's sales figures are 4 times better in the first weeks. We got a small taste of that with a 5% increase last Friday. In the after-market in US, it continued up to price 265. It looks good for the coming months when the pill comes to Europe. Everyone wants Novo's pill and not a lot of copy pills you die from. What good does it do to get thin from Eli Lilly's pill or copy pills, if you die from it !!!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
82 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Viimeisin osinko
4,50%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·20 min sittenStock market gains on the way in Europe, here is Monday's financial overview. We are entering a hectic week, where we will get fresh insights into some of the largest and most influential companies both domestically and abroad. European stocks are set to become more valuable when stock trading kicks off in Europe. Futures for European stocks currently indicate price increases of 0.3 pct. when looking at the Euro Stoxx 50 index. The index covers 50 large European companies. Good day to all ☀️
- 8 t sitten8 t sittenFra Reddit - Imagine this conversation: "Sry honey, I'm gonna lose less weight, feel nauseous and you will have to wrap your willy for 30 days for likely quite a few times...." "Or.... i could just take the other pill, priced the exact same, that makes me thinner, feel healthier, and oh yeah,... i have to just wait a few minutes in the morning before eating, which hey.... i wasn't planning to do anyway because I'm planning to lose weight right!" Easiest choice ever. LLY is so f'd
- ·9 t sitten · MuokattuCan recommend this on Reddit (might explain why Foundayo has been slow to start so far): https://www.reddit.com/r/Burryology/comments/1sv6rkz/lly_the_foundayo_bull_case_requires_assuming/ "- Here's the kicker I suspect nobody is pricing in. Foundayo's FDA label requires women on oral birth control to either switch to non-oral contraception OR use condoms for 30 days after starting AND 30 days after each dose escalation. That's 3-6 months of continuous backup contraception to reach max dose.[2] - Oral Wegovy has no such warning. Semaglutide was directly studied for oral contraceptive interaction. No clinically meaningful effect. Zero friction, so to say." And: "One final thing is Wegovy pill already has more weight loss but lot.of users are kind of bio hacking it now - they realized if you extend the fasting window to 1-2 hours it can dramatically increase the effectiveness. The 30 minute was made for convenience but concentration is almost doubled in your blood if you wait 1-2 hours. That's not a trick you can do with Foundayo since it has no fasting restrictions so the advantage in that aspect is now a disadvantage."·9 t sittenProtector you might want to read along here before you babble too much !!!
- ·12 t sitten·9 t sittenThere is no doubt that Q1 and Q2 will be challenged. It has already been announced that 2026 will bring a double-digit underlying decline. Wegovy pill form has enormous success, but it cannot change the picture yet. If we are lucky, we will see results in Q2 that make it less severe, but we can hope it is correct that EMA will announce something very soon. If Wegovy pill form comes to the European market in 2-3 months, then Wegovy pill form might grow so large that it cancels out the expected underlying double-digit decline. Honestly, when it comes to market in Europe, I am convinced that for many, many months, the number of patients/users will grow month after month. Clearly, the sooner it is approved, the better, but if it comes to market in July, I believe that globally by end of December it can yield 4-6 million patients/users.
- ·16 t sittenI think the American and also analysts will soon wake up. They have until now set price targets based on Novo's share price and not Novo's real value. Now some current sales figures came out last Friday. It shows that doctors prefer to prescribe the Novo pill. That is so clear with the uncertainty surrounding Eli Lilly's pill with side effects. Novo's sales figures are 4 times better in the first weeks. We got a small taste of that with a 5% increase last Friday. In the after-market in US, it continued up to price 265. It looks good for the coming months when the pill comes to Europe. Everyone wants Novo's pill and not a lot of copy pills you die from. What good does it do to get thin from Eli Lilly's pill or copy pills, if you die from it !!!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 | - | - | ||
| 20 | - | - | ||
| 702 | - | - | ||
| 571 | - | - | ||
| 129 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
2025 Q4 -tulosraportti
82 päivää sitten
‧1 t 12 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 |
7,95 DKK/osake
Viimeisin osinko
4,50%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·20 min sittenStock market gains on the way in Europe, here is Monday's financial overview. We are entering a hectic week, where we will get fresh insights into some of the largest and most influential companies both domestically and abroad. European stocks are set to become more valuable when stock trading kicks off in Europe. Futures for European stocks currently indicate price increases of 0.3 pct. when looking at the Euro Stoxx 50 index. The index covers 50 large European companies. Good day to all ☀️
- 8 t sitten8 t sittenFra Reddit - Imagine this conversation: "Sry honey, I'm gonna lose less weight, feel nauseous and you will have to wrap your willy for 30 days for likely quite a few times...." "Or.... i could just take the other pill, priced the exact same, that makes me thinner, feel healthier, and oh yeah,... i have to just wait a few minutes in the morning before eating, which hey.... i wasn't planning to do anyway because I'm planning to lose weight right!" Easiest choice ever. LLY is so f'd
- ·9 t sitten · MuokattuCan recommend this on Reddit (might explain why Foundayo has been slow to start so far): https://www.reddit.com/r/Burryology/comments/1sv6rkz/lly_the_foundayo_bull_case_requires_assuming/ "- Here's the kicker I suspect nobody is pricing in. Foundayo's FDA label requires women on oral birth control to either switch to non-oral contraception OR use condoms for 30 days after starting AND 30 days after each dose escalation. That's 3-6 months of continuous backup contraception to reach max dose.[2] - Oral Wegovy has no such warning. Semaglutide was directly studied for oral contraceptive interaction. No clinically meaningful effect. Zero friction, so to say." And: "One final thing is Wegovy pill already has more weight loss but lot.of users are kind of bio hacking it now - they realized if you extend the fasting window to 1-2 hours it can dramatically increase the effectiveness. The 30 minute was made for convenience but concentration is almost doubled in your blood if you wait 1-2 hours. That's not a trick you can do with Foundayo since it has no fasting restrictions so the advantage in that aspect is now a disadvantage."·9 t sittenProtector you might want to read along here before you babble too much !!!
- ·12 t sitten·9 t sittenThere is no doubt that Q1 and Q2 will be challenged. It has already been announced that 2026 will bring a double-digit underlying decline. Wegovy pill form has enormous success, but it cannot change the picture yet. If we are lucky, we will see results in Q2 that make it less severe, but we can hope it is correct that EMA will announce something very soon. If Wegovy pill form comes to the European market in 2-3 months, then Wegovy pill form might grow so large that it cancels out the expected underlying double-digit decline. Honestly, when it comes to market in Europe, I am convinced that for many, many months, the number of patients/users will grow month after month. Clearly, the sooner it is approved, the better, but if it comes to market in July, I believe that globally by end of December it can yield 4-6 million patients/users.
- ·16 t sittenI think the American and also analysts will soon wake up. They have until now set price targets based on Novo's share price and not Novo's real value. Now some current sales figures came out last Friday. It shows that doctors prefer to prescribe the Novo pill. That is so clear with the uncertainty surrounding Eli Lilly's pill with side effects. Novo's sales figures are 4 times better in the first weeks. We got a small taste of that with a 5% increase last Friday. In the after-market in US, it continued up to price 265. It looks good for the coming months when the pill comes to Europe. Everyone wants Novo's pill and not a lot of copy pills you die from. What good does it do to get thin from Eli Lilly's pill or copy pills, if you die from it !!!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 20 | - | - | ||
| 20 | - | - | ||
| 702 | - | - | ||
| 571 | - | - | ||
| 129 | - | - |
Välittäjätilasto
Dataa ei löytynyt